每年出版 6 期
ISSN 打印: 1040-8401
ISSN 在线: 2162-6472
Indexed in
The Immunology of Corneal Graft Rejection
摘要
Corneal transplantation is the most successful of organ transplants due to the fact that the eye is an immunologically privileged site, and the cornea is an immunologically privileged tissue. The factors responsible for this include presence of the blood-aqueous barrier, the avascularity of the cornea, the absence of classic antigen-presenting cells (APCs) in the central cornea, inhibitory factors in the aqueous humor, the phenomenon known as anterior chamber-associated immune deviation (ACAID), and the intraocular expression of Fas ligand. Loss of ocular immune privilege can occur with breaching of the blood-ocular barrier, corneal neovascularization, migration of classic APCs to the center of the cornea, loss of inhibitory factors in aqueous humor, abrogation of ACAID, and loss of Fas ligand expression within the anterior chamber. The purpose of this review is to analyze these events and how they relate to corneal graft rejection. A discussion on future research and therapeutic modalities is provided.
-
ALBON JULIE, CORNEAL TRANSPLANTATION AND THE ARTIFICIAL CORNEA, Journal of Mechanics in Medicine and Biology, 03, 01, 2003. Crossref
-
Huang M-C, Tullo A B, Hillarby M C, Increased Rac2 mRNA expression in peripheral blood during human corneal graft rejection, Eye, 23, 2, 2009. Crossref
-
Dekaris Iva, Gabrić Nikica, Drača Nataša, Pauk-Gulić Maja, Miličić Neven, Three-year corneal graft survival rate in high-risk cases treated with subconjunctival and topical bevacizumab, Graefe's Archive for Clinical and Experimental Ophthalmology, 253, 2, 2015. Crossref
-
Hamrah Pedram, Pavan-Langston Deborah, Dana Reza, Herpes Simplex Keratitis and Dendritic Cells at the Crossroads, International Ophthalmology Clinics, 49, 1, 2009. Crossref
-
Jia Liang, Liu Yong, Wang Liqiang, Zhu Jing, Huang Yifei, Effects of Topical Sphingosine-1-Phosphate 1 Receptor Agonist on Corneal Allograft in Mice, Cornea, 33, 4, 2014. Crossref
-
Bradley Benjamin A, Rejection and recipient age, Transplant Immunology, 10, 2-3, 2002. Crossref
-
Dapena Isabel, Ham Lisanne, Netuková Magdaléna, van der Wees Jacqueline, Melles Gerrit R J, Incidence of Early Allograft Rejection After Descemet Membrane Endothelial Keratoplasty, Cornea, 30, 12, 2011. Crossref
-
Xiao He, Zhang Han, Yu Zu-Yin, Zhang Lei, Yu Ming, Huang Yi-Fei, Li Song, Shen Bei-Fen, Li Yan, J2 prolongs the corneal allograft survival through inhibition of the CD4+ T cell-mediated response in vivo, Transplant Immunology, 18, 2, 2007. Crossref
-
Stevenson William, Cheng Sheng-Fu, Dastjerdi Mohammad H., Ferrari Giulio, Dana Reza, Corneal Neovascularization and the Utility of Topical VEGF Inhibition: Ranibizumab (Lucentis) Vs Bevacizumab (Avastin), The Ocular Surface, 10, 2, 2012. Crossref
-
NIEDERKORN JERRY Y., DANA M. REZA, Immune System and the Eye, in Ocular Therapeutics, 2008. Crossref
-
Klebe Sonja, Coster Douglas J, Rozenbilds M A. Michael, A Practical Approach to Interpretation of Corneal Specimens, Advances in Anatomic Pathology, 11, 3, 2004. Crossref
-
Ziaei Mohammed, Sharif-Paghaleh Ehsan, Manzouri Bita, Pharmacotherapy of corneal transplantation, Expert Opinion on Pharmacotherapy, 13, 6, 2012. Crossref
-
Kim Yun-Gon, Oh Joo Youn, Gil Geun-Cheol, Kim Mee Kum, Ko Jung Hwa, Lee Sukmook, Lee Hyun Ju, Wee Won Ryang, Kim Byung-Gee, Identification of α-Gal and non-Gal Epitopes in Pig Corneal Endothelial Cells and Keratocytes by Using Mass Spectrometry, Current Eye Research, 34, 10, 2009. Crossref
-
Boost Maureen, Cho Pauline, Wang Zhaoran, Disturbing the balance: effect of contact lens use on the ocular proteome and microbiome, Clinical and Experimental Optometry, 100, 5, 2017. Crossref
-
Lee King C., Zheng Li-Mou, Luo Xiang, Clairmont Caroline, Fischer Jessica, Margitich Dennis, Turnier John, Almassian Bijan, Bermudes David, King Ivan, Comparative Evaluation of the Acute Toxic Effects in Monkeys, Pigs and Mice of a Genetically Engineered Salmonella Strain (VNP20009) Being Developed as an Antitumor Agent, International Journal of Toxicology, 19, 1, 2000. Crossref
-
Pastak Marko, Kleff Veronika, Saban Daniel R., Czugala Marta, Steuhl Klaus-Peter, Ergün Süleyman, Singer Bernhard B., Fuchsluger Thomas A., Gene Therapy for Modulation of T-Cell-Mediated Immune Response Provoked by Corneal Transplantation, Human Gene Therapy, 29, 4, 2018. Crossref
-
Dixon Janet A., Reynolds Irena, Zeggini Eleftheria, Tullo Andrew B., Chantal Hillarby M., Fas mRNA EXPRESSION IN BLOOD IS REDUCED DURING EPISODES OF HUMAN CORNEAL GRAFT REJECTION1, Transplantation, 71, 5, 2001. Crossref
-
Ghaffari Reza, Ghassemi Hamed, Zarei-Ghanavati Mehran, Latifi Golshan, Dehghani Shima, Haq Zeeshan, Djalilian Ali R., Tacrolimus Eye Drops as Adjunct Therapy in Severe Corneal Endothelial Rejection Refractory to Corticosteroids, Cornea, 36, 10, 2017. Crossref
-
Doganay Selim, Hepsen I. Fevzi, Yologlu Saim, Demirtas Hakan, Effect of the Preservation-to-Surgery Interval on Corneal Allograft Survival in Low-Risk Patients, Ophthalmic Surgery, Lasers and Imaging Retina, 38, 6, 2007. Crossref
-
Giannaccare Giuseppe, Pellegrini Marco, Bovone Cristina, Spena Rossella, Senni Carlotta, Scorcia Vincenzo, Busin Massimo, Anti-VEGF Treatment in Corneal Diseases, Current Drug Targets, 21, 12, 2020. Crossref
-
Igney Frederik H., Krammer Peter H., Immune escape of tumors: apoptosis resistance and tumor counterattack, Journal of Leukocyte Biology, 71, 6, 2002. Crossref